Catalyst Calendar - March 31, 2026 (Morning)

 ## Major Catalysts Mentioned **AIRO Group Holdings** - Date: Q4 2025 earnings call (Date TBD) - Why it matters: The company reported a Q4 2025 earnings miss leading to a nearly 14% stock decline, indicating potential operational or market challenges. Investors should monitor follow-up guidance and strategic responses. - Stocks affected: **$AIRO** **Skeena Resources** - Date: Bond offering planned (Date TBD) - Why it matters: Plans for a $750 million bond offering to fund the Eskay Creek project could impact the company's capital structure and growth prospects, affecting investor sentiment. - Stocks affected: data not available **US EXIM Board** - Date: Loan advancement for Stibnite Gold Project (Date TBD) - Why it matters: The $2.7 billion loan approval supports a major mining project, potentially boosting related mining and resource stocks. - Stocks affected: Mining sector broadly, including **$NEM**, **$BMEA** **Denali Therapeutics** - Date: FDA approval and $200 million royalty agreement (Date TBD) - Why it matters: The FDA approval and subsequent royalty deal provide a significant revenue boost and validation for Denali’s HIT therapy pipeline. - Stocks affected: **$DNL** (data not available), **$BMEA** (related biotech sector) **Lilly (Eli Lilly & Co.)** - Date: Acquisition deal announced (Date TBD) - Why it matters: Lilly’s plan to pay up to $7.8 billion to acquire a company developing a narcolepsy drug signals expansion in its neuroscience portfolio, potentially driving growth and market share. - Stocks affected: **$LLY** **McCormick & Company and Unilever** - Date: Food business merger talks and deal near completion (Date TBD) - Why it matters: The merger valued near $45 billion could reshape the consumer staples landscape, creating synergies and scale benefits. - Stocks affected: **$MKC**, **$UL** (Unilever, data not available) **Trump’s Iran War Exit Signals** - Date: Reported on 3/31/2026 - Why it matters: Reports that former President Trump is willing to end the Iran war without reopening the Strait of Hormuz could ease geopolitical tensions, impacting oil prices and energy stocks. - Stocks affected: Energy sector broadly, **$USO**, **$XOM** (data not available) **Jensen Huang/Nvidia** - Date: Order outlook raised to $1 trillion (Date TBD) - Why it matters: Nvidia’s raised order outlook underscores strong demand for AI chips, reinforcing its leadership in the AI sector and potentially driving semiconductor sector momentum. - Stocks affected: **$NVDA**, **$MRVL**, **$AMD** (data not available) **FactSet Research Systems** - Date: FY2026 guidance raised and Q2 earnings beat (Date TBD) - Why it matters: Upgraded earnings and sales guidance indicate strong business momentum in financial data services, supporting stock strength. - Stocks affected: **$FDS** ## Earnings on Deck - **$AIRO** - Q4 2025 earnings call (Date TBD) - Key watch: Earnings miss and stock reaction - **$FDS** - Q2 earnings beat and FY2026 guidance raise (Date TBD) - Key watch: Adjusted EPS and sales growth - **$BMEA** - New trials for diabetes drug (Date TBD) - Key watch: Clinical progress and potential revenue impact - **$SPCE** - Q4 2025 earnings call (Date TBD) - Key watch: Earnings miss but stock rise on testing progress - **$PHR** - Q4 2026 earnings call (Date TBD) - Key watch: Outlook and revenue trends - **$BMY** - Pipeline strength and valuation (Date TBD) - Key watch: Survey launch and pipeline updates - **$JBS** - Q4 2025 earnings call (Date TBD) - Key watch: Operational results and guidance - **$MINISO** - Q4 2025 earnings call (Date TBD) - Key watch: Earnings miss and revenue beat - **$SOFI** - Analyst target price discussion (Date TBD) - Key watch: Valuation and growth outlook - **$RGTI** - Expansion plans and rating upgrade (Date TBD) - Key watch: Quantum computing growth potential - **$RKLB** - Defense contract and rating upgrade (Date TBD) - Key watch: Contract impact on revenue - **$CRWD** - Partnership implications (Date TBD) - Key watch: Growth from new partnerships - **$RACE** - Pricing power and rating upgrade (Date TBD) - Key watch: Revenue and margin trends - **$RPAY** - M&A call (Date TBD) - Key watch: Deal impact on growth - **$BMEA** - Diabetes drug trial start (Date TBD) - Key watch: Clinical trial progress - **$BIOA** - Data inspires confidence (Date TBD) - Key watch: Clinical data and pipeline progress - **$CRSP** - Gene editing growth (Date TBD) - Key watch: Market positioning and growth - **$VICI** - Casino acquisition rating reiteration (Date TBD) - Key watch: Acquisition impact - **$HPE** - Analyst initiation (Date TBD) - Key watch: Valuation and growth outlook ## Economic Events - JOLTS Job Openings for February 2026 - March 31, 2026, 2:00 PM Expected to provide insight into labor market tightness with forecast at 6.918M, slightly down from previous 6.946M. - CaseShiller 20-City Home Price Index for January 2026 - March 31, 2026, 1:00 PM Forecast shows modest home price gains, signaling housing market trends. - Chicago PMI for March 2026 - March 31, 2026, 1:45 PM Forecast at 55, down from 57.7, indicating potential manufacturing sector slowdown. - Consumer Confidence for March 2026 - March 31, 2026, 2:00 PM Forecast at 88, down from 91.2, reflecting cautious consumer sentiment. - API Weekly Petroleum Data - March 31, 2026, 8:30 PM Key for oil market supply/demand balance amid geopolitical tensions. ## Regulatory & Legal - No explicit FDA decisions or regulatory rulings with dates mentioned beyond Denali Therapeutics’ royalty agreement post-FDA approval (date TBD). ## What's NOT Dated But Worth Tracking - Ongoing geopolitical tensions in the Middle East, particularly the Iran war and its impact on oil prices, energy stocks, and global markets. - The evolving AI sector, with Nvidia’s leadership and related semiconductor stocks benefiting from strong demand and raised outlooks. - The merger and acquisition activity in consumer staples, notably McCormick and Unilever’s food business deal, which could reshape the sector. - Bitcoin’s near-record six-month losing streak and related crypto market volatility, with potential implications for blockchain and fintech stocks. - The UK Competition and Markets Authority investigation into Microsoft’s business software ecosystem, which could affect Microsoft’s operations and valuation. - Rising inflation and stagflation risks in Europe, as highlighted by Goldman Sachs, which may influence portfolio rotations and sector allocations. ## Highest Conviction Catalyst - What: Trump’s reported willingness to end the Iran war without reopening the Strait of Hormuz (reported on March 31, 2026) - When: March 31, 2026 (report date) - Why it matters: This development could significantly ease geopolitical risk premiums that have been driving oil prices to four-year highs and fueling energy sector volatility. A de-escalation may relieve inflationary pressures from energy costs and stabilize markets sensitive to Middle East tensions. This event has broad implications for energy stocks, commodities, and global market sentiment. - Trade idea: Consider reducing hedges on oil and energy stocks such as **$USO** and **$XOM** (data not available) if the de-escalation gains confirmation, while monitoring related geopolitical news closely for sustained impact. --- This briefing highlights explicit dates and events from recent headlines, focusing on actionable catalysts and market-moving developments. Investors should watch earnings from key companies like **$AIRO**, **$FDS**, and **$BMEA**, alongside critical economic data releases on March 31, 2026, that will provide further clarity on labor, housing, and consumer trends amid ongoing geopolitical uncertainty.